文献速递消化系统肿瘤支持与姑息治疗

西班牙结直肠癌患者多重共病与短期总死亡率:基于人群的队列研究

Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study.
PubMed 文献 · Eur J Cancer · 2020-02-27

该研究基于西班牙两个基于人群的癌症登记处和电子健康记录,纳入1061例结直肠癌患者,评估多重共病与6个月和1年短期死亡率的关联。结果显示,多重共病患者6个月死亡风险为无共病者的2.04倍(95%CI 1.30-3.20),最常见共病模式为充血性心力衰竭+糖尿病,而风湿病+糖尿病患者1年死亡风险为2.23倍(95%CI 1.23-4.07)。

要点

  • 多重共病是结直肠癌患者6个月和1年短期死亡的独立预测因素。
  • 6个月调整后死亡风险比HR为2.04(95%CI 1.30-3.20)。
  • 风湿病+糖尿病模式1年死亡风险HR为2.23(95%CI 1.23-4.07)。

核心结论

  • 多重共病是西班牙结直肠癌患者6个月和1年短期死亡的强独立预测因素。
  • 所识别的多重共病模式与短期死亡风险升高一致相关。

研究设计与样本

  • 基于西班牙两个基于人群的癌症登记处和电子健康记录的人群队列研究。
  • 纳入1061例结直肠癌患者,其中324例(30.5%)存在多重共病。

主要发现

  • 171例(16.2%)在6个月内死亡,246例(23.3%)在1年随访内死亡。
  • 多重共病患者6个月死亡风险为无共病者的2.04倍(调整HR 2.04;95%CI 1.30-3.20;p=0.002)。
  • 最常见多重共病模式为充血性心力衰竭+糖尿病。
  • 风湿病+糖尿病患者1年死亡风险为无共病者的2.23倍(HR 2.23;95%CI 1.23-4.07;p=0.008)。

临床怎么用

  • 可依据多重共病状态识别结直肠癌短期死亡高风险患者。
  • 对合并充血性心力衰竭+糖尿病或风湿病+糖尿病的患者应加强风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous studies have analysed the effect of comorbidity on cancer outcomes, but evidence on the association between multimorbidity and short-term mortality among colorectal cancer patients is limited. We aimed to assess this association and the most frequent patterns of multimorbidity associated with a higher short-term mortality risk among colorectal cancer patients in Spain. METHODS: Data were obtained from two Spanish population-based cancer registries and electronic health records. We estimated the unadjusted cumulative incidence of death by comorbidity status at 6 months and 1 year. We used a flexible parametric model to derive the excess mortality hazard ratios (HRs) for multimorbidity after adjusting for sex, age at diagnosis, cancer stage and treatment. We estimated the adjusted cumulative incidence of death by comorbidity status and identified multimorbidity patterns. RESULTS: Among the study participants, 1,048 cases were diagnosed with cancers of the colon and rectum, 2 cases with cancer of the anus with overlapping sites of the rectum and 11 cases with anal adenocarcinomas but treated as colorectal cancer patients. Among 1,061 colorectal cancer patients, 171 (16.2%) died before 6 months, 246 (23.3%) died before the 1-year follow-up, and 324 (30.5%) had multimorbidity. Patients with multimorbidity had two times higher mortality risk than those without comorbidities at 6 months (adjusted HR: 2.04; 95% confidence interval [CI]: 1.30-3.20, p = 0.002). The most frequent multimorbidity pattern was congestive heart failure + diabetes. However, patients with rheumatologic disease + diabetes had two times higher 1-year mortality risk than those without comorbidities (HR: 2.23; 95% CI: 1.23-4.07, p = 0.008). CONCLUSIONS: Multimorbidity was a strong independent predictor of short-term mortality at 6 months and 1 year among the colorectal cancer patients in Spain. The identified multimorbidity pattern was consistent. Our findings might help identify patients at a higher risk for poor cancer and treatment outcomes.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Luque-Fernandez MA, Gonçalves K, Salamanca-Fernández E, et al. Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study. Eur J Cancer. 2020. PMID: 32114366. doi:10.1016/j.ejca.2020.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。